Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2021 Earnings Conference Call March 14, 2022 8:30 AM ET Company Participants Juli Miller - Investor Relations Adrian Rawcliffe - Chief Executive Officer Dennis Williams - Senior Vice President, Late Stage Development Elliot Norry - Chief Medical Officer John Lunger - Chief Patient Supply Officer Helen Tayton-Martin - Chief Business Officer Karen Miller - Senior Vice President, Pipeline Research Gavin Wood - Chief Financial Officer Conference Call Participants Ma ...